Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“Subcutaneous injection of ropivacaine 0.25% or 0.75% decreased cutaneous blood flow by a maximum of 52% +/- 11% and 54% +/- 14% (mean +/- SE ), respectively.”